- Home
- XTNT vs DALN Comparison
XTNT vs DALN Comparison
Compare XTNT & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- DALN
- Stock Information
- Founded
- XTNT N/A
- DALN 1954
- Country
- XTNT United States
- DALN United States
- Employees
- XTNT N/A
- DALN N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- DALN Newspapers/Magazines
- Sector
- XTNT Health Care
- DALN Consumer Discretionary
- Exchange
- XTNT Nasdaq
- DALN Nasdaq
- Market Cap
- XTNT 60.9M
- DALN 72.6M
- IPO Year
- XTNT N/A
- DALN 2008
- Fundamental
- Price
- XTNT $0.62
- DALN $13.72
- Analyst Decision
- XTNT
- DALN
- Analyst Count
- XTNT 0
- DALN 0
- Target Price
- XTNT N/A
- DALN N/A
- AVG Volume (30 Days)
- XTNT 96.0K
- DALN 333.5K
- Earning Date
- XTNT 08-07-2025
- DALN 07-29-2025
- Dividend Yield
- XTNT N/A
- DALN N/A
- EPS Growth
- XTNT N/A
- DALN N/A
- EPS
- XTNT N/A
- DALN 5.55
- Revenue
- XTNT $122,298,000.00
- DALN $123,414,000.00
- Revenue This Year
- XTNT $11.64
- DALN N/A
- Revenue Next Year
- XTNT $7.59
- DALN N/A
- P/E Ratio
- XTNT N/A
- DALN $2.49
- Revenue Growth
- XTNT 20.81
- DALN N/A
- 52 Week Low
- XTNT $0.33
- DALN $2.98
- 52 Week High
- XTNT $0.80
- DALN $13.80
- Technical
- Relative Strength Index (RSI)
- XTNT 44.76
- DALN 93.25
- Support Level
- XTNT $0.56
- DALN $13.63
- Resistance Level
- XTNT $0.67
- DALN $13.80
- Average True Range (ATR)
- XTNT 0.05
- DALN 0.21
- MACD
- XTNT -0.01
- DALN 0.87
- Stochastic Oscillator
- XTNT 21.14
- DALN 99.12
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.